| | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $511,643 ) |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218 | BALTIMORE CITY | USA | Arthritis, Musculoskeletal and Skin Diseases Research | 001 | 5 | 3/4/2026 | NON-COMPETING CONTINUATION | $511,643 |
| | 2026 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218 | BALTIMORE CITY | USA | Arthritis, Musculoskeletal and Skin Diseases Research | 000 | 4 | 12/17/2025 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2025 ( Subtotal = $518,627 ) |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218 | BALTIMORE CITY | USA | Arthritis, Musculoskeletal and Skin Diseases Research | 001 | 4 | 3/17/2025 | NON-COMPETING CONTINUATION | $518,627 |
| | 2025 | 2024 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218 | BALTIMORE CITY | USA | Arthritis, Musculoskeletal and Skin Diseases Research | 000 | 3 | 12/20/2024 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $525,474 ) |
| | 2024 | 2024 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218 | BALTIMORE CITY | USA | Arthritis, Musculoskeletal and Skin Diseases Research | 002 | 3 | 6/13/2024 | NON-COMPETING CONTINUATION | $0 |
| | 2024 | 2024 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218 | BALTIMORE CITY | USA | Arthritis, Musculoskeletal and Skin Diseases Research | 001 | 3 | 2/29/2024 | NON-COMPETING CONTINUATION | $525,474 |
| | 2024 | 2023 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218 | BALTIMORE CITY | USA | Arthritis, Musculoskeletal and Skin Diseases Research | 000 | 2 | 1/16/2024 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $532,188 ) |
| | 2023 | 2023 | JOHNS HOPKINS UNIVERSITY, THE | 3400 N CHARLES ST | BALTIMORE | MD | 21218 | BALTIMORE CITY | USA | Arthritis, Musculoskeletal and Skin Diseases Research | 000 | 2 | 7/19/2023 | NON-COMPETING CONTINUATION | $532,188 |
|
|